Braveheart Investment Group’s Trevor Brown on recent raise and COVID-19 test development plans

0 1
() () Trevor Brown comments on the recent raise of around £2.5mln in a share placing.  This will be used to 'push forward quickly' the development of a COVID-19 testing instrument by its subsidiary Paraytec. The firm plans to take direct control of the final design and engineering packages, while Paraytec will continue to seek out partners for licensing and development as well as a potential sale. Add related topics to MyProactive Create your account: sign up and get ahead on news and events NO INVESTMENT ADVICE The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is... In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash..
Subscribe or log in to read the rest of this content.
Leave A Reply

Your email address will not be published.